• 1
    McLuen EF, Fouts JR. The effect of obstructive jaundice on drug metabolism in rabbits. J Pharmacol Exp Ther 1961; 131:17.
  • 2
    Denk H, Greim H, Hutterer F, Schaffner F, Popper H. Turnover of hepatic cytochrome P450 in experimental cholestasis. Exp Mol Pathol 1973; 19:241247. MEDLINE
  • 3
    Hutterer F, Denk H, Bacchin PG, Schenkman JB, Schaffner F, Popper H. Mechanism of cholestasis. 1. Effect of bile acids on microsomal cytochrome P450-dependent biotransformation system in vivo. Life Sci 1970; 9:877887.
  • 4
    Hutterer F, Denk H, Bacchin PG, Schenkman JB, Schaffner F, Popper H. Mechanism of cholestasis. 2. Effect of bile acids on microsomal cytochrome P450–dependent biotransformation system in vivo. Life Sci 1970; 9:11591166.
  • 5
    Mackinnon AM, Simon FR. Reduced synthesis of hepatic microsomal cytochrome P450 in the bile duct ligated rats. Biochem Biophys Res Commun 1974; 56:437443. MEDLINE
  • 6
    Chen J, Farrell GC. Bile acids produce a generalized reduction of the catalytic activity of cytochromes P450 and other hepatic microsomal enzymes in vitro: relevance to drug metabolism in experimental cholestasis. J Gastoenterol Hepatol 1996; 11:870877.
  • 7
    Chen J, Murray M, Jiang X-M, Liddle C, Farrell GC. Down-regulation of male-specific cytochrome P450s 2C11 and 3A2 in bile duct-ligated male rats; importance to reduced hepatic content of cytochrome P450 cholestasis. Hepatology 1995; 22:580587. MEDLINE
  • 8
    Schaffner F, Bacchin PG, Hutterer F. Mechanism of cholestasis. 4. Structural and biochemical changes in the liver and serum in rats after bile duct-ligation. Gastroenterology 1971; 60:888897. MEDLINE
  • 9
    Kitani K, Kanai S, Ohta M, Tsukahara K. Ursodeoxycholate (UDC) prevents the hepatocellular damage caused by other bile salts as its conjugates in rats. Hepatology 1988; 8:14561460.
  • 10
    Kitani K, Ohta M, Kanai S. Tauroursodeoxycholate prevents biliary protein excretion induced by other bile salts in the rat. Am J Physiol 1985; 248:G407G417. MEDLINE
  • 11
    Roda A, Piazza F, Baraldini M, Speroni E, Guerra MC, Cerrè C, Cantelli-Forti G. Taurohyodeoxycholic acid protects against taurochenodeoxycholic acid–induced cholestasis in the rat. Hepatology 1998; 27:520525. MEDLINE
  • 12
    Kitani K, Kanai S, Sato Y, Ohta M. Tauro α-muricholate is as effective as Tauro β-muricholate and tauroursodeoxycholate in preventing the hepatocyte damage caused by continuous infusion of taurochenodeoxycholate in the rat. Hepatology 1994; 19:10111012.
  • 13
    Kitani K, Kanai S, Ohta M. The preventive effects of glycine conjugates of ursodeoxycholate, β-muricholate on taurochenodeoxycholate induced cholestasis in the rat. Acta Hepatol Jpn 34(Suppl): 10111012.
  • 14
    Kanai S, Ohta M, Kitani K, Sato Y. Tauro β-muricholate is as effective as tauroursodeoxycholate in preventing taurochenodeoxycholate-induced liver damage in the rat. Life Sci 1990; 47:24212428. MEDLINE
  • 15
    Roda A, Cerré C, Manetta AC, Cainelli G, Umani-Ronchi A, Panunzio M. Synthesis and physicochemical, biological and pharmacological properties of new bile acids amidated with cyclic amino acids. J Med Chem 1996; 39:22702276. MEDLINE
  • 16
    Roda A, Pellicciari R, Polimeni C, Cerré C, Cantelli Forti G, Sadeghpour B, Sapigni E, et al. Metabolism, pharmacokinetics, and activity of a new 6-fluoro analogue of ursodeoxycholic acid in rats and hamsters. Gastroenterology 1995; 108:12041214. MEDLINE
  • 17
    Ward A, Brogden AN, Heel RC, Speight TM, Avery GS. Ursodeoxycholic acid: a review of its pharmacological properties and therapeutic efficacy. Drugs 1984; 27:95131. MEDLINE
  • 18
    Kaplan MM, Righetti A. Induction of rat liver alkaline phosphatase: the mechanism of the serum elevation in bile duct obstruction. J Clin Invest 1970; 49:508516. MEDLINE
  • 19
    Kaplan MM, Onkubo A, Quaroni EG, Sze-Tu D. Increased synthesis of rat liver alkaline phosphatase by bile duct ligation. Hepatology 1983; 3:433439. MEDLINE
  • 20
    Gurantz D, Schteingart CD, Hagey LR, Steinbach JH, Grotmol T, Hofmann AF. Hypercholeresis induced by unconjugated bile acids infusion correlates with recovery in bile of unconjugated bile acids. Hepatology 1991; 13:340550.
  • 21
    Gerloff T, Stieger B, Hagenbuch B, Madon J, Landmann L, Roth J, Hofmann AF, et al. The sister of P-glycoprotein represents the canalicular bile salt export pump of mammalian liver. J Biol Chem 1998; 273:1004610050. MEDLINE
  • 22
    Salphati L, Bernet LZ. Modulation of P-glycoprotein expression by cytochrome P450 inducers in male and female rat livers. Biochemical Pharmacol 1998; 55:387395.
  • 23
    Accatino L, Pizarro M, Solis N, Koenig CS, Vollrath V, Chianale J. Modulation of hepatic content and biliary excretion of P-glycoprotein in hepatocellular and obstructive cholestasis in rat. J Hepatol 1996; 25:349361. MEDLINE
  • 24
    Poupon RE, Poupon R, Balkau B. Ursodiol for the long-term treatment of primary biliary cirrhosis. N Engl J Med 1994; 330:13421347. MEDLINE
  • 25
    Loria P, Bozzoli M, Angelico M, Bertolotti M, Carubbi F, Concari M, Baiochi L, et al. Effect of taurohyodeoxycholic acid on biliary lipid secretion in man; preliminary report. Ital J Gastroenterol 1996; 28:391392. MEDLINE
  • 26
    Paolini M, Mesirca R, Pozzetti L, Sapone A, Cantelli-Forti G. Induction of CYP 2B1 mediated pentoxyresorufin O-dealkylase activity in different species, sex and tissue by prototype 2B1-inducers. Chem Biol Interact 1995; 95:127139. MEDLINE
  • 27
    Bauer C, Corsi C, Paolini M. Stability of microsomal monooxygenases in murine liver S9 fractions derived from phenobarbital and β-naphthoflavone induced animals under various long-term conditions of storage. Teratogen Carcin Mut 1994; 14:1322.
  • 28
    Omura T, Sato R. The carbon monoxide–binding pigment of liver microsomes I. Evidences for its hemoprotein nature. J Biol Chem 1964; 239:23702378.
  • 29
    Bruce M. Microsomal NADPH cytochrome c-reductase. Methods Enzymol 1967; 10:551553.
  • 30
    Coutts RD, Pings F, Baker B. Involvement of CYP2D6, Cyp3A4 and other cytochrome P-450 isoenzymes in N-dealkylation reactions. J Pharmacol Toxicol Methods 1994; 31:177186. MEDLINE
  • 31
    Mazel P. Fundamentals of Drug Metabolism and Drug Disposition. Baltimore: Williams and Wilkins. 1971; 546550.
  • 32
    Nash T. Colorimetric estimation of formaldehyde by means of Hantzsch reaction. Biochem J 1953; 55:416421.
  • 33
    Koop DR, Laethem CL, Tierny DJ. The utility of p-nitrophenol hydroxylation in P450IIE1. Drug Metab Rev 1989; 20:541551. MEDLINE
  • 34
    Reinke LA, Mayer MJ. p-Nitrophenol hydroxylation. A microsomal oxydation which is highly inducible by ethanol. Drug Metab Disp 1985; 13:548552.
  • 35
    Lubet RA, Mayer MJ, Cameron JW, Raymond WN, Burke M, Wolf T, Guengerich FP. Dealkylation of pentoxyresorufin. A rapid and sensitive assay for measuring induction of cytochrome(s) P450 by phenobarbital and other xenobiotics in rat. Arch Biochem Biophys 1985; 238:4348. MEDLINE
  • 36
    Madra S, Smith AG. Induction of cytochrome P450 activities by polychlorinated biphenyls in isolated mouse hepatocytes. Influence of Ah-phenotype and iron. Biochem Pharmacol 1992; 44:455464. MEDLINE
  • 37
    Burke MD, Thompson S, Elcombe CR, Halpert J, Haaparant T, Meyer RT. Ethoxy-, pentoxy- and benzyloxy-phenoxazones and homologues: a series of substrates to distinguish between different induced cytochromes P450. Biochem Pharmacol 1985; 34:33373345. MEDLINE
  • 38
    Aitio A. A simple and sensitive assay of 7-ethoxycoumarin deethylation. Anal Biochem 85: 33373345.
  • 39
    Paolini M, Mesirca R, Pozzetti L, Sapone A, Cantelli-Forti G. Testosterone hydroxylase in evaluating induction and suppression of murine CYP isoenzymes by fenarimol. Arch Toxicol 1996; 70:451456. MEDLINE
  • 40
    Platt J, Molitor E, Doehmer J, Dogra S, Oesch F. Genetically engineered V79 Chinese hamster cell. Expression of purified cytochrome P450 2B1 monooxygenase activity. Biochem Toxicol 1989; 4:15.
  • 41
    Van der Hoeven TH. Assay of hepatic microsomal testosterone hydroxylases by high-performance liquid chromatography. Anal Biochem 1984; 138:5765. MEDLINE
  • 42
    Chung WG, Cha YN. Oxidation of caffeine to theobromine and theophillyne is catalyzed primarly by flavin-containing monooxygenase in liver microsomes. Biochem Biophys Res Commun 1997; 235:685688. MEDLINE
  • 43
    Lowry OH, Rosenbrough HJ, Farr AL, Randall RJ. Protein measurement with Folin phenol reagent. J Biol Chem 1951; 193:265275.
  • 44
    Bailey YL. Techniques in Protein Chemistry. Amsterdam: Elsevier. 1967; 340341.
  • 45
    Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227:680685. MEDLINE
  • 46
    Towbin H, Stachelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A 1979; 76:43504354. MEDLINE
  • 47
    Dutton DR, Reed GA, Parkinson A. Redox cycling of resorufin catalysed by rat liver microsomal NADPH-cytochrome P450 reductase. Arch Biochem Biophys 1989; 268:605616. MEDLINE
  • 48
    Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162:156159. MEDLINE
  • 49
    Seed B. Genetic engineering: Principles and methods. Volume 4. StelowJK, HollanderA, eds. New York: Plenum, 1982:91.
  • 50
    Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning, A Laboratory Manual. 2nd ed. New York: Cold Spring Harbor Laboratory Press. 156159.
  • 51
    Paolini M, Mesirca R, Pozzetti L, Maffei F, Vigagni F, Hrelia P, Cantelli-Forti G. Genetic and non-genetic biomarkers related to carcinogenesis in evaluating toxicological risk from fenarimol. Mutat Res 1996; 368:2739. MEDLINE
  • 52
    Box GEP, Hunter WG. Statistics for Experiments. New York: Wiley. 1978; 8082.
  • 53
    Roda A, Minutello A, Angelotti MA, Fini A. Bile acids structure-activity relationship: evaluation of bile acid lipophilicity using 1-octanol/water partition coefficient and reverse phase HPLC. J Lipid Res 1990; 31:14331443. MEDLINE
  • 54
    Roda A, Hofmann AF, Mysels KJ. The influence of bile salt structure on self association in aqueous solutions. J Biol Chem 1983; 258:63626370. MEDLINE
  • 55
    Takahashi N, Miranda CL, Henderson MC, Buhler DR, Williams DE, Bailey GS. Inhibition of in vitro aflatoxin B1-DNA binding in rainbow trout by CYP1A inhibitors: alpha-naphthoflavone, beta-naphthoflavone and trout CYP1A1 peptide antibody. Comp Biochem Physiol C Pharmacol Toxicol Endocrinol 1995; 110:273280. MEDLINE
  • 56
    Ferro M, Marinari UM, Bassi AM, Nanni G. Biochemical properties of carcinogen-metabolizing enzymes in cultured hepatoma cells. 1 Toxicol Patol 1987; 15:97102.
  • 57
    Shefer S, Zaki FG, Salen G. Early morphologic and anzymatic changes in livers of rats treated with chenodeoxycholic and ursodeoxycholic acids. Hepatology 1983; 3:201208. MEDLINE
  • 58
    Poupon R, Poupon RE, Calmus Y. Is ursodeoxycholic acid an effective treatment for primary biliary cirrhosis? Lancet 1987; i:834836.
  • 59
    Matsuzaki Y, Tanaka N, Osuga T. Improvement of biliary enzyme levels and itching as a result of long-term administration or ursodeoxycholic acid in primary biliary chirrosis. Am J Gastroenterol 1990; 85:1523. MEDLINE
  • 60
    Longo V, Ingelam-Sunberg M. Acetone-dependent regulation of cytochromes P4502E1 and P4502B1 in rat nasal mucosa. Biochem Pharmacol 1993; 46:19451951. MEDLINE
  • 61
    Koop DR, Tierney DJ. Multiple mechanisms in the regulation of ethanol-inducible cytochrome P4502E1. Bio Essay 1990; 12:429435.
  • 62
    Ingelman-Sundberg M. Ethanol-inducible cytochrome P4502E1. Regulation, radical formation and toxicological importance. In: PoliG, AlbanoE, DianzaniM, eds. Oxy Radicals. Basel: Birkenhauser. 1993; 287301.
  • 63
    Sinclar J, Cornel NW, Zaitlin L, Hansch C. Induction of cytochrome P450 by alcohols and 4-substituted pyrazoles. Comparison of the structure-activity relationships. Biochem Pharmacol 1986; 35:707710. MEDLINE
  • 64
    Paolini M, Pozzetti L, Sapone A, Mesirca R, Perocco P, Mazzullo M, Cantelli-Forti G. Molecular non-genetic biomarkers of effect related to acephate cocarcinogenesis: sex- and tissue-dependent induction or suppression of murine CYPs. Cancer Lett 1997; 117:715. MEDLINE
  • 65
    Paolini M, Mesirca R, Pozzetti L, Sapone A, Cantelli-Forti G. Biomarkers of effect in evaluating dithianon cocarcinogenesis: selective induction and suppression of murine CYP3A isoform. Cancer Lett 1997; 113:221228. MEDLINE
  • 66
    Kamimoto Y, Gatmaitan Z, Hsu J, Arias IM. The function of GP170, the multidrug resistence gene product, in rat liver canalicular membrane vesicles. J Biol Chem 1989; 264:1169311698. MEDLINE
  • 67
    Holloway DE, Rivers JM. Influence of chronic ascorbic acid deficiencyand excessive ascorbic acid intake on bile acid metabolism and bile composition in the guinea pig. J Nutr 1981; 111:412424. MEDLINE
  • 68
    Fukuda H, Iritani N. The binding of cholic acid to protein in rat serum and liver. J Biochem Tokyo 1981; 90:17571762. MEDLINE
  • 69
    Zumber A, Zusman I. Effects of secondary bile acids on the intrauterine development in rats. Teratology 1990; 42:215224. MEDLINE
  • 70
    Andress JM, Frith CH, Goodman DG, Boysen BG, Cook CS. The mouse. In: Cox GadS, ChengelisCP eds. Animal Model in Toxicology. New York: Dekker. 1992; 165294.